NZYM-B.CO
Price:
$397.4
Market Cap:
$23.52B
Novozymes A/S, established in 1925 and headquartered in Bagsvaerd, Denmark, specializes in the development and provision of biological solutions, primarily industrial enzymes, microorganisms, and probiotics. Operating across Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America, the company offers a comprehensive range of products for various sectors. In the food and beverage industry, Novozymes provides solutions for baking, dairy, starch processing, beverages, and protein applications. For household care, its offerings include solutions for laundry, dishwashing, and professional cleaning. The agricultural sector benefits from its support in crop production, an...[Read more]
Industry
Chemicals - Specialty
IPO Date
2000-11-20
Stock Exchange
CPH
Ticker
NZYM-B.CO
According to Novozymes A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 26.41B. This represents a change of -85.99% compared to the average of 188.44B of the last 4 quarters.
The mean historical Enterprise Value of Novozymes A/S over the last ten years is 120.50B. The current 26.41B Enterprise Value has changed 2.09% with respect to the historical average. Over the past ten years (40 quarters), NZYM-B.CO's Enterprise Value was at its highest in in the September 2024 quarter at 234.81B. The Enterprise Value was at its lowest in in the December 2016 quarter at 74.04B.
Average
120.50B
Median
104.80B
Minimum
74.15B
Maximum
191.23B
Discovering the peaks and valleys of Novozymes A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 73.70%
Maximum Annual Enterprise Value = 191.23B
Minimum Annual Increase = -30.61%
Minimum Annual Enterprise Value = 74.15B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 191.23B | 1.67% |
| 2024 | 188.09B | 73.70% |
| 2023 | 108.28B | 4.86% |
| 2022 | 103.26B | -30.61% |
| 2021 | 148.82B | 46.33% |
| 2020 | 101.70B | 4.91% |
| 2019 | 96.94B | 12.45% |
| 2018 | 86.21B | -18.93% |
| 2017 | 106.34B | 43.40% |
| 2016 | 74.15B | -27.01% |
The current Enterprise Value of Novozymes A/S (NZYM-B.CO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
162.53B
5-year avg
147.94B
10-year avg
120.50B
Novozymes A/S’s Enterprise Value is less than Coloplast A/S (109.70B), greater than Chr. Hansen Holding A/S (9.62B), greater than GN Store Nord A/S (22.81B), less than FLSmidth & Co. A/S (29.30B), less than DSV A/S (460.00B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 109.70B | $86.54B | |
| 9.62B | $72.33B | |
| 22.81B | $13.71B | |
| 29.30B | $27.41B | |
| 460.00B | $375.86B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novozymes A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Novozymes A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Novozymes A/S's Enterprise Value?
What is the highest Enterprise Value for Novozymes A/S (NZYM-B.CO)?
What is the 3-year average Enterprise Value for Novozymes A/S (NZYM-B.CO)?
What is the 5-year average Enterprise Value for Novozymes A/S (NZYM-B.CO)?
How does the current Enterprise Value for Novozymes A/S (NZYM-B.CO) compare to its historical average?